I.e., I don’t think ASMB has been cynically downplaying HBsAg because ABI-H0731 had little effect on HBsAg, but rather because ASMB’s scientists sincerely believe that HBsAg is the wrong biomarker to focus on.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.